Stem cell model of diabetic kidney disease identifies inflammation as a therapeutic target
Stem cell researchers have identified inflammatory pathways that may play a key role in driving kidney damage in diabetic kidney disease (DKD), pointing to potential new approaches for protecting the kidneys. Using stem cell-derived kidney organoids, Dr. Benjamin Freedman and colleagues from the University of Washington found that exposure to high sugar levels triggered inflammation and disrupted…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
